Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Tobacco smoke-exposed children more often use emergent health services

Tobacco smoke-exposed children utilize emergency and urgent care services more often than unexposed children, which contributes to a large toll on the nation's health care system, says research led by the University of Cincinnati.

24 Mar 2021

Researchers produce a detailed molecular atlas of lung development

Researchers at the Perelman School of Medicine at the University of Pennsylvania have produced a detailed molecular atlas of lung development, which is expected to be a fundamental reference in future studies of mammalian biology and of new treatments for diseases, such as COVID-19, that affect the lungs.

24 Mar 2021

New covalent and non-covalent SARS-CoV-2 inhibitors discovered in silico

A new study describes the use of a combination of virtual and experimental screening protocols to identify potential inhibitors of the virus, which could lead to rapid drug development.

24 Mar 2021

Delays in TB diagnosis often exceed WHO’s recommendations, shows study

Tuberculosis remains a rare disease in the United States, but when it does occur, delays in diagnosing it often exceed recommendations by the World Health Organization, according to a new report by Harvard Medical School researchers published March 22 in The Lancet Infectious Diseases.

24 Mar 2021

Survey of surge capacity managers captures pandemic preparedness status of the U.S. health care system

A University of Pittsburgh School of Medicine-led survey of dozens of surge capacity managers at hospitals nationwide captures the U.S. health care system's pandemic preparedness status in the months before the first COVID-19 cases were identified in China.

24 Mar 2021

Delaying second doses of COVID-19 vaccines can reduce positive cases

Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term; however, the longer term case burden and the potential for evolution of viral ‘escape’ from immunity will depend on the robustness of immune responses generated by natural infections and one or two vaccine doses, according to a study from McGill University and Princeton University published today in Science.

24 Mar 2021

New range of lung-on-chip technologies represent the vital properties of lung tissue

According to the National Institutes of Health, respiratory viruses are the most frequent cause of disease and death in humans, a fact highlighted by the COVID-19 pandemic. Despite the potential to cause severe disease, over 70% of viral infections remain asymptomatic.

24 Mar 2021

People who received flu shot last season had fewer complication of COVID-19

People who received a flu shot last flu season were significantly less likely to test positive for a COVID-19 infection when the pandemic hit, according to a new study.

23 Mar 2021

Survey findings reveals persistence of COVID-19 vaccine hesitancy

Daily national surveys by Carnegie Mellon University show that while COVID-19 vaccine uptake has increased, the proportion of vaccine-hesitant adults has remained unchanged. The concerns about a side effect remain high, especially among females, Black adults and those with an eligible health condition.

23 Mar 2021

Research identifies ways to prevent coronavirus spread to the nervous system

A number of studies have shown that human coronaviruses, including SARS-CoV-2 which causes COVID-19, appear to attack neurons and the nervous system in vulnerable populations.

23 Mar 2021

COVID-19 prevention strategies may have led to a decrease in common respiratory infections

Wearing masks and physical distancing - two key infection prevention strategies implemented to stop the spread of COVID-19 - may have led to the dramatic decrease in rates of common respiratory viral infections, such as influenza.

23 Mar 2021

‘Zombie’ cells come to life after the death of the brain

In the hours after we die, certain cells in the human brain are still active. Some cells even increase their activity and grow to gargantuan proportions, according to new research from the University of Illinois Chicago.

23 Mar 2021

A new COVID-19 candidate vaccine induces robust humoral and cellular immune responses in mice

A Korea-based company EyeGene Inc. has recently developed a liposome-based mRNA candidate vaccine against COVID-19, which contains full-length spike protein of the European variant (D614G) of SARS-CoV-2 as a vaccine antigen.

23 Mar 2021

B.1.1.7 SARS-CoV-2 variant significantly more dangerous

Now, researchers at the University of Exeter, the NHS Foundation Trust, report a significant increase in mortality risk due to the B.1.1.7 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant.

22 Mar 2021

New method could drive down the production cost of antibodies

Antibody injections are a highly desirable treatment for people with chronic diseases such as cancer, psoriasis, Crohn's disease and arthritis. And recently, antibodies have been in the news as a promising treatment for severe cases of COVID-19.

22 Mar 2021

SARS-CoV-2 infection is circadian

An international team of researchers has found that angiotensin-converting enzyme 2 (ACE2) levels in lung cells vary over the day, affecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The virus entry and replication in the lung cells also have a rhythmic cycle, suggesting circadian processes can affect the virus's life cycle.

22 Mar 2021

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that it has acted on a request to provide opaganib treatment on an outpatient basis under compassionate use exemption for several Swiss patients suffering from COVID-19 pneumonia.

22 Mar 2021

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

Results from a large clinical trial in the United States and South America indicate that AstraZeneca's COVID-19 vaccine, AZD1222, is well-tolerated and protects against symptomatic COVID-19 disease, including severe disease or hospitalization.

22 Mar 2021

Can SARS-CoV-2 still be transmissible once symptoms have subsided?

Researchers based at the University of Missouri, in partnership with U.S. government science facilities in Maryland, have reported that individuals severely infected with SARS-CoV-2 may be able to continue shedding infectious viral RNA for over three weeks after the symptomatic infection has passed.

22 Mar 2021

Male fertility and androgen production may be impacted by COVID-19

An interesting new study has appeared online in the journal Hormones that discusses the effects of COVID-19 on the male and female gonads.

22 Mar 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Tobacco smoke-exposed children more often use emergent health services

Researchers produce a detailed molecular atlas of lung development

New covalent and non-covalent SARS-CoV-2 inhibitors discovered in silico

Delays in TB diagnosis often exceed WHO’s recommendations, shows study

Survey of surge capacity managers captures pandemic preparedness status of the U.S. health care system

Delaying second doses of COVID-19 vaccines can reduce positive cases

New range of lung-on-chip technologies represent the vital properties of lung tissue

People who received flu shot last season had fewer complication of COVID-19

Survey findings reveals persistence of COVID-19 vaccine hesitancy

Research identifies ways to prevent coronavirus spread to the nervous system

COVID-19 prevention strategies may have led to a decrease in common respiratory infections

‘Zombie’ cells come to life after the death of the brain

A new COVID-19 candidate vaccine induces robust humoral and cellular immune responses in mice

B.1.1.7 SARS-CoV-2 variant significantly more dangerous

New method could drive down the production cost of antibodies

SARS-CoV-2 infection is circadian

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

Can SARS-CoV-2 still be transmissible once symptoms have subsided?

Male fertility and androgen production may be impacted by COVID-19

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in